Literature DB >> 36222918

[Abdominal soft tissue tumors].

Eva Wardelmann1, Anna Kuntze2, Marcel Trautmann2, Wolfgang Hartmann2.   

Abstract

Gastrointestinal stromal tumors are the most common mesenchymal tumors in the abdomen and occur in Germany with an incidence of 10 to 15 cases per million inhabitants. Clear identification and characterization are of major importance for the prognosis and therapy of patients. Similarly, they have to be differentiated from other mesenchymal neoplasias such as leiomyomatous, neurogenic, adipocytic, and fibroblastic tumors. Additionally, the number of translocation positive neoplasias is increasing, requiring the use of adequate molecular assays. The aim of this paper is to give practical advice for their identification. Reference pathology is one possibility to support the correct diagnosis.
© 2022. The Author(s).

Entities:  

Keywords:  GIST; Molecular classification; Reference pathology; Soft tissue tumors; Translocation-positive neoplasias

Year:  2022        PMID: 36222918     DOI: 10.1007/s00292-022-01128-7

Source DB:  PubMed          Journal:  Pathologie (Heidelb)        ISSN: 2731-7188


  30 in total

Review 1.  Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.

Authors:  Sebastian Huss; Sandra Elges; Marcel Trautmann; Jan Sperveslage; Wolfgang Hartmann; Eva Wardelmann
Journal:  Expert Rev Anticancer Ther       Date:  2015-04-01       Impact factor: 4.512

Review 2.  Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.

Authors:  Sebastian Huss; Helen Pasternack; Michaela Angelika Ihle; Sabine Merkelbach-Bruse; Birthe Heitkötter; Wolfgang Hartmann; Marcel Trautmann; Heidrun Gevensleben; Reinhard Büttner; Hans-Ulrich Schildhaus; Eva Wardelmann
Journal:  Hum Pathol       Date:  2017-02-01       Impact factor: 3.466

Review 3.  Gastrointestinal stromal tumors: pathology and prognosis at different sites.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

Review 4.  Gastrointestinal Stromal Tumors: What Is the Best Sequence of TKIs?

Authors:  Jordan Senchak; Katya Ahr; Margaret von Mehren
Journal:  Curr Treat Options Oncol       Date:  2022-03-28

Review 5.  The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor.

Authors:  Inga-Marie Schaefer; Ronald P DeMatteo; César Serrano
Journal:  Am Soc Clin Oncol Educ Book       Date:  2022-04

6.  Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors.

Authors:  Eva Wardelmann; Inge Losen; Volkmar Hans; Iris Neidt; Nicola Speidel; Erhard Bierhoff; Thomas Heinicke; Torsten Pietsch; Reinhard Büttner; Sabine Merkelbach-Bruse
Journal:  Int J Cancer       Date:  2003-10-10       Impact factor: 7.396

7.  Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.

Authors:  Barbara Pasini; Sarah R McWhinney; Thalia Bei; Ludmila Matyakhina; Sotirios Stergiopoulos; Michael Muchow; Sosipatros A Boikos; Barbara Ferrando; Karel Pacak; Guillaume Assie; Eric Baudin; Agnes Chompret; Jay W Ellison; Jean-Jacques Briere; Pierre Rustin; Anne-Paule Gimenez-Roqueplo; Charis Eng; J Aidan Carney; Constantine A Stratakis
Journal:  Eur J Hum Genet       Date:  2007-08-01       Impact factor: 4.246

Review 8.  New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors.

Authors:  César Serrano; Sebastian Bauer
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

9.  Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P G Casali; J Y Blay; N Abecassis; J Bajpai; S Bauer; R Biagini; S Bielack; S Bonvalot; I Boukovinas; J V M G Bovee; K Boye; T Brodowicz; A Buonadonna; E De Álava; A P Dei Tos; X G Del Muro; A Dufresne; M Eriksson; A Fedenko; V Ferraresi; A Ferrari; A M Frezza; S Gasperoni; H Gelderblom; F Gouin; G Grignani; R Haas; A B Hassan; N Hindi; P Hohenberger; H Joensuu; R L Jones; C Jungels; P Jutte; B Kasper; A Kawai; K Kopeckova; D A Krákorová; A Le Cesne; F Le Grange; E Legius; A Leithner; A Lopez-Pousa; J Martin-Broto; O Merimsky; C Messiou; A B Miah; O Mir; M Montemurro; C Morosi; E Palmerini; M A Pantaleo; R Piana; S Piperno-Neumann; P Reichardt; P Rutkowski; A A Safwat; C Sangalli; M Sbaraglia; S Scheipl; P Schöffski; S Sleijfer; D Strauss; S J Strauss; K Sundby Hall; A Trama; M Unk; M A J van de Sande; W T A van der Graaf; W J van Houdt; T Frebourg; A Gronchi; S Stacchiotti
Journal:  Ann Oncol       Date:  2021-09-21       Impact factor: 32.976

Review 10.  Syndromic gastrointestinal stromal tumors.

Authors:  Riccardo Ricci
Journal:  Hered Cancer Clin Pract       Date:  2016-07-19       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.